CSF3 and cervical carcinoma: To evaluate the impact of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) on radiotherapy completion rates and safety in cervical cancer patients undergoing concurrent chemoradiotherapy.